Doctor profile · Federal record
Dr. JOSHUA REUSS, MD
Medical Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Student in an Organized Health Care Education/Training Program · WASHINGTON, DC
- NPI 1740609825
- Accepts Medicare
- MIPS 75.7 / 100 · 2023
- 12 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
3800 RESERVOIR ROAD NW LCCC, PODIUM B
WASHINGTON, DC 200072113
(202) 444-2223 - Additional location
-
1215 Lee St, Box 800744
Charlottesville, VA 229080816
(434) 924-1931
fax (434) 243-5770 - Additional location
-
1650 Orleans Street, CRB 1 - 186
Baltimore, MD 21287
(410) 955-8893
fax (410) 367-2194
Credentials & registration
- NPI registered
- April 2014 — 12 yrs on file
- Profile last updated
- June 17, 2020
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Maryland #D84259
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740609825. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
355
Distinct HCPCS
4
Medicare allowed
$57,242
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 271 | 59 | $159 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 38 | 19 | $132 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 24 | 24 | $202 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 22 | 21 | $193 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 100. This provider delivers 3.6× the peer median.Open Payments
Industry payments received
All-time total
$31,041
Transactions
37
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $8,132.54 | |
| Lilly USA, LLC | 2 | $5,200.00 | |
| Novocure Inc. | 4 | $3,691.96 | |
| Regeneron Pharmaceuticals, Inc. | 5 | $3,097.19 | |
| Merck Sharp & Dohme LLC | 1 | $2,440.00 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $1,929.97 | |
| Daiichi Sankyo Europe GmbH | 1 | $1,875.00 | |
| AstraZeneca UK Limited | 3 | $1,668.81 | |
| ARRAY BIOPHARMA INC | 3 | $1,543.64 | |
| Daiichi Sankyo Inc. | 3 | $990.94 | |
| JAZZ PHARMACEUTICALS INC. | 2 | $281.41 | |
| Gilead Sciences, Inc. | 1 | $101.91 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $88.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
58
Patients
0
Total drug cost
$283,130
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 18 | 0 | $103 |
| Tagrisso (Osimertinib Mesylate) | Brand | 16 | 0 | $276,856 |
| Erlotinib Hcl | Generic | 12 | 0 | $6,021 |
| Ondansetron Hcl | Generic | 12 | 0 | $150 |